CN110381990A - 马的瘙痒症的治疗 - Google Patents

马的瘙痒症的治疗 Download PDF

Info

Publication number
CN110381990A
CN110381990A CN201880016752.3A CN201880016752A CN110381990A CN 110381990 A CN110381990 A CN 110381990A CN 201880016752 A CN201880016752 A CN 201880016752A CN 110381990 A CN110381990 A CN 110381990A
Authority
CN
China
Prior art keywords
seq
amino acid
acid sequence
eil
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880016752.3A
Other languages
English (en)
Chinese (zh)
Inventor
A·费特尔肖斯
V·费特尔肖斯
M·巴赫曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evax AG
University of Bern
Zurich Universität
Original Assignee
Evax AG
University of Bern
Zurich Universität
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evax AG, University of Bern, Zurich Universität filed Critical Evax AG
Publication of CN110381990A publication Critical patent/CN110381990A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5409—IL-5

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN201880016752.3A 2017-03-07 2018-03-07 马的瘙痒症的治疗 Pending CN110381990A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17159644.8 2017-03-07
EP17159644 2017-03-07
PCT/EP2018/055644 WO2018162577A1 (en) 2017-03-07 2018-03-07 Treatment of pruritus in horses

Publications (1)

Publication Number Publication Date
CN110381990A true CN110381990A (zh) 2019-10-25

Family

ID=58397991

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880016752.3A Pending CN110381990A (zh) 2017-03-07 2018-03-07 马的瘙痒症的治疗

Country Status (7)

Country Link
US (3) US11207390B2 (enExample)
EP (1) EP3592378A1 (enExample)
JP (1) JP7365240B2 (enExample)
CN (1) CN110381990A (enExample)
AU (1) AU2018231413B2 (enExample)
CA (1) CA3054389A1 (enExample)
WO (1) WO2018162577A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3093709C (en) 2018-03-16 2024-03-26 Zoetis Services Llc Peptide vaccines against interleukin-31
JP7449234B2 (ja) 2018-03-16 2024-03-13 ゾエティス・サービシーズ・エルエルシー 獣医学使用のためのインターロイキン３１モノクローナル抗体
AU2019278596A1 (en) * 2018-05-28 2020-12-24 Evax Ag Treatment of urticaria
WO2021083766A1 (en) 2019-10-29 2021-05-06 Evax Ag Treatment of pruritus in horses
CA3211221A1 (en) * 2021-02-22 2022-08-25 Zoetis Services Llc Horse il-31 induced pruritus model
CN119136838A (zh) 2022-02-28 2024-12-13 特瑞德姆生物科技有限责任两合公司 由至少一种β-葡聚糖或甘露聚糖组成或包含至少一种β-葡聚糖或甘露聚糖的偶联物
AR133291A1 (es) * 2023-07-19 2025-09-17 Inst Pasteur De Montevideo Inmunización activa para el tratamiento de la dermatitis atópica

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1558775A (zh) * 2001-11-07 2004-12-29 \ 用于治疗变应性嗜酸细胞性疾病的展示il-5、il-3或嗜酸细胞活化趋化因子的抗原阵列
WO2016062720A1 (en) * 2014-10-22 2016-04-28 Saiba Gmbh Modified virus-like particles of cmv

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7264810B2 (en) 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
US10556003B2 (en) * 2015-09-08 2020-02-11 Universität Zürich Treatment of insect bite hypersensitivity
US10093731B2 (en) * 2017-02-24 2018-10-09 Kindred Biosciences, Inc. Anti-IL31 antibodies for veterinary use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1558775A (zh) * 2001-11-07 2004-12-29 \ 用于治疗变应性嗜酸细胞性疾病的展示il-5、il-3或嗜酸细胞活化趋化因子的抗原阵列
WO2016062720A1 (en) * 2014-10-22 2016-04-28 Saiba Gmbh Modified virus-like particles of cmv

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GINA M. MICHELS ET AL.: "A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis", 《VET DERMATOL》 *
YU ZOU ET AL.: "Combined vaccination against IL-5 and eotaxin blocks eosinophilia in mice", 《VACCINE》 *

Also Published As

Publication number Publication date
JP7365240B2 (ja) 2023-10-19
WO2018162577A1 (en) 2018-09-13
US11207390B2 (en) 2021-12-28
AU2018231413B2 (en) 2024-01-04
EP3592378A1 (en) 2020-01-15
CA3054389A1 (en) 2018-09-13
JP2020510700A (ja) 2020-04-09
US20220168405A1 (en) 2022-06-02
AU2018231413A1 (en) 2019-09-12
US20250281582A1 (en) 2025-09-11
US20200016248A1 (en) 2020-01-16

Similar Documents

Publication Publication Date Title
US12226475B2 (en) Treatment of insect bite hypersensitivity
US20250281582A1 (en) Treatment of pruritus in horses
JP2020510700A5 (enExample)
KR102469478B1 (ko) 개 아토피성 피부염의 치료
JP2025118600A (ja) じんましんの治療
CN119789863A (zh) 经修饰的cmv病毒样颗粒
WO2021083766A1 (en) Treatment of pruritus in horses
HK1252263B (en) Treatment of insect bite hypersensitivity

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination